← Companies
Invivyd, Inc.
Data as of Nov 11, 2026
Reported federal lobbying
$460K
12 filings · latest Oct 20, 2026
Federal contracts since 2024
$0
2 awards · latest Nov 19, 2024
Lobbying
$460,000 in reported federal lobbying spend across 12 quarterly filings, most recently Oct 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$300K6 filings
- Manufacturing +1$120K2 filings
Latest filings, Apr 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Oct 20, 2026 | FORBES-TATE for INVIVYD Health Issues Issues related to infectious diseases. | $120,000 |
| Oct 1, 2026 | INVIVYD, INC. for INVIVYD INC. Manufacturing · Health Issues Onshoring, Domestic manufacturing
Monoclonal Antibodies, Infectious diseases | $60,000 |
| Jul 20, 2026 | FORBES-TATE for INVIVYD Health Issues Issues related to infectious diseases. | $120,000 |
| Jun 24, 2026 | INVIVYD, INC. for INVIVYD INC. Manufacturing · Health Issues Onshoring, Domestic manufacturing
Monoclonal Antibodies, Infectious diseases | $60,000 |
| Apr 28, 2026 | KING & SPALDING LLP for INVIVYD INC. Unspecified | $0 |
| Apr 23, 2026 | INVIVYD, INC. for INVIVYD INC. Unspecified | $20,000 |